These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

273 related items for PubMed ID: 24911364

  • 21. Relapsing migratory idiopathic orbital inflammation: six new cases and review of the literature.
    Avni-Zauberman N, Tripathy D, Rosen N, Ben Simon GJ.
    Br J Ophthalmol; 2012 Feb; 96(2):276-80. PubMed ID: 21527417
    [Abstract] [Full Text] [Related]

  • 22. A case of non-lacrimal immunoglobulin G4 (IgG4)-related orbital disease with mastitis.
    Farooq TA, Mudhar H, Sandramouli S.
    Orbit; 2016 Feb; 35(1):16-9. PubMed ID: 26700191
    [Abstract] [Full Text] [Related]

  • 23. Pediatric Idiopathic Orbital Inflammation: Clinical Features of 30 Cases.
    Spindle J, Tang SX, Davies B, Wladis EJ, Piozzi E, Pellegrini M, Lally SE, Shields C, Shinder R.
    Ophthalmic Plast Reconstr Surg; 2016 Feb; 32(4):270-4. PubMed ID: 27337659
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. IgG4-related disease in patients with idiopathic orbital inflammation.
    Aryasit O, Tiraset N, Preechawai P, Kayasut K, Sanghan N, Sittivarakul W.
    BMC Ophthalmol; 2021 Oct 08; 21(1):356. PubMed ID: 34625052
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Ocular adnexal IgG4-related disease: clinical features, outcome, and factors associated with response to systemic steroids.
    Yu WK, Kao SC, Yang CF, Lee FL, Tsai CC.
    Jpn J Ophthalmol; 2015 Jan 08; 59(1):8-13. PubMed ID: 25373451
    [Abstract] [Full Text] [Related]

  • 30. Sclerosing idiopathic orbital inflammation.
    Brannan PA, Kersten RC, Kulwin DR.
    J Pediatr Ophthalmol Strabismus; 2006 Jan 08; 43(3):183-4. PubMed ID: 16761644
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Clinical Features and Treatment Outcomes of Orbital Inflammatory Disease in Singapore: A 10-Year Clinicopathologic Review.
    Young SM, Chan ASY, Jajeh IA, Shen S, Seah LL, Choo CT, Lang SS, Looi ALG.
    Ophthalmic Plast Reconstr Surg; 2017 Jan 08; 33(3):182-188. PubMed ID: 27097061
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Rituximab for the treatment of IgG4-related orbital disease: experience from five cases.
    Wu A, Andrew NH, Tsirbas A, Tan P, Gajdatsy A, Selva D.
    Eye (Lond); 2015 Jan 08; 29(1):122-8. PubMed ID: 25341435
    [Abstract] [Full Text] [Related]

  • 40. Idiopathic Orbital Inflammation Appearing on the Affected Side of Preceding Myasthenia Gravis.
    Fujita S, Furuta N, Maruyama T, Tsukagoshi S, Nagashima K, Fujita Y, Nagai K, Kashima T, Tanaka M, Miki I, Yamazaki A, Ikota H, Oyama T, Ikeda Y.
    Intern Med; 2020 Jan 08; 59(14):1763-1767. PubMed ID: 32669516
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 14.